These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 16189745

  • 1. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.
    Kieser M, Szegedi A.
    Pharmacopsychiatry; 2005 Sep; 38(5):194-200. PubMed ID: 16189745
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M.
    Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
    [Abstract] [Full Text] [Related]

  • 3. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 5. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
    Kasper S, Dienel A.
    Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R, Trautmann-Sponsel RD, Kieser M.
    Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C, Mehlsen J, Thomsen CF, Hedman C, von Fircks H, Winther K.
    Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
    [Abstract] [Full Text] [Related]

  • 8. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
    Szegedi A, Kohnen R, Dienel A, Kieser M.
    BMJ; 2005 Mar 05; 330(7490):503. PubMed ID: 15708844
    [Abstract] [Full Text] [Related]

  • 9. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R, Azbel V, Madhusoodanan S, Pawlowska M.
    Clin Ther; 2000 Apr 05; 22(4):411-9. PubMed ID: 10823363
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y, Clerc G, Didi R, Kieser M.
    Am J Psychiatry; 2002 Aug 05; 159(8):1361-6. PubMed ID: 12153829
    [Abstract] [Full Text] [Related]

  • 11. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP, Murck H, Kasper S, Möller HJ.
    Psychopharmacology (Berl); 2002 Nov 05; 164(3):294-300. PubMed ID: 12424553
    [Abstract] [Full Text] [Related]

  • 12. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
    Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M.
    BMC Med; 2006 Jun 23; 4():14. PubMed ID: 16796730
    [Abstract] [Full Text] [Related]

  • 13. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
    Schulz V.
    Phytomedicine; 2002 Jul 23; 9(5):468-74. PubMed ID: 12222670
    [Abstract] [Full Text] [Related]

  • 14. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D, Zobel I, Dykierek P, Deimel CM, Kech S, Lieb K, Berger M, Schramm E.
    J Affect Disord; 2009 Apr 23; 114(1-3):243-53. PubMed ID: 18849079
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.
    Laakmann G, Dienel A, Kieser M.
    Phytomedicine; 1998 Dec 23; 5(6):435-42. PubMed ID: 23196026
    [Abstract] [Full Text] [Related]

  • 16. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
    Trautmann-Sponsel RD, Dienel A.
    J Affect Disord; 2004 Oct 15; 82(2):303-7. PubMed ID: 15488262
    [Abstract] [Full Text] [Related]

  • 17. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep 15; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 18. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A, Schmidt M, Hauke W, Stade K.
    Phytomedicine; 2011 Jun 15; 18(8-9):739-42. PubMed ID: 21514125
    [Abstract] [Full Text] [Related]

  • 19. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression.
    Sayyah M, Sayyah M, Kamalinejad M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 15; 30(1):166-9. PubMed ID: 16309809
    [Abstract] [Full Text] [Related]

  • 20. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Jan 15; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.